Investigation of potential schizophrenic pathways with the IL-2/TREM-1 pathway reveals possible complexes or drugs responsible for novel treatment of schizophrenia and hepatocellular carcinoma. This evidence concerns the gene TREM1 and hepatocellular carcinoma.